This review highlights translational research on the role of carotid body chemoreceptors in metabolic conditions.
Answers are grounded in this paper and cite their sources.
Should not yet change metabolic disease management; leaves open the need for interventional trials on carotid body modulation.
Known primarily for its oxygen-sensing capabilities, the carotid body chemoreceptors have recently been implicated, primarily by work in animal models, in the pathophysiology of a number of metabolic conditions. The research presented in this brief review highlights translational work conducted at the Mayo Clinic between 2010 and 2017 in healthy humans and discusses key areas for future work in disease populations.
No takes yet. Share an insight, caveat, or question.
Jacqueline K. Limberg (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: